Traphagen Investment Advisors LLC Merck & Co., Inc. Transaction History

Traphagen Investment Advisors LLC

$868 Million
Q3 2024

A detailed history of Traphagen Investment Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Traphagen Investment Advisors LLC holds 9,062 shares of MRK stock, worth $921,061. This represents 0.12% of its overall portfolio holdings.

Number of Shares

9,062

Previous 8,679 4.41%

Holding current value

$921,061

Previous $1.07 Million 4.19%

% of portfolio

0.12%

Previous 0.13%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$111.15 - $128.97 $42,570 - $49,395	383 Added 4.41%	9,062 $1.03 Million
Q2 2024 Jul 23, 2024	BUY	$123.8 - $132.96 $32,064 - $34,436	259 Added 3.08%	8,679 $1.07 Million
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $953,480 - $1.11 Million	8,420 New	8,420 $1.11 Billion
Q4 2023 Jun 17, 2024	SELL	$100.18 - $109.02 $6,611 - $7,195	-66 Reduced 0.78%	8,354 $911 Million
Q3 2023 Jun 17, 2024	SELL	$102.95 - $114.33 $81,227 - $90,206	-789 Reduced 9.37%	7,631 $786 Million
Q2 2023 Jun 17, 2024	SELL	$108.61 - $118.38 $86,779 - $94,585	-799 Reduced 9.49%	7,621 $879 Million
Q1 2023 Jun 17, 2024	BUY	$102.94 - $114.86 $29,234 - $32,620	284 Added 3.93%	7,516 $800 Million
Q4 2022 Jun 17, 2024	SELL	$87.44 - $112.11 $103,878 - $133,186	-1,188 Reduced 14.11%	7,232 $802 Million
Q3 2022 Jun 17, 2024	SELL	$84.53 - $94.96 $4,480 - $5,032	-53 Reduced 0.71%	7,410 $638 Million
Q2 2022 Jun 17, 2024	SELL	$83.49 - $94.64 $79,899 - $90,570	-957 Reduced 11.37%	7,463 $680 Million
Q1 2022 Jun 17, 2024	BUY	$73.51 - $82.4 $48,957 - $54,878	666 Added 9.96%	7,351 $603 Million
Q4 2021 Jun 17, 2024	SELL	$72.28 - $90.54 $125,405 - $157,086	-1,735 Reduced 20.61%	6,685 $512 Million
Q3 2021 Jun 17, 2024	BUY	$71.68 - $78.83 $788 - $867	11 Added 0.17%	6,553 $492 Million
Q2 2021 Jun 17, 2024	SELL	$70.31 - $77.77 $5,976 - $6,610	-85 Reduced 1.28%	6,542 $509 Million
Q1 2021 Jun 17, 2024	SELL	$68.86 - $81.11 $123,465 - $145,430	-1,793 Reduced 21.29%	6,627 $511 Million
Q4 2020 Jun 17, 2024	SELL	$71.77 - $79.65 $2,942 - $3,265	-41 Reduced 0.63%	6,418 $525 Million
Q3 2020 Jun 17, 2024	BUY	$73.18 - $82.95 $3,293 - $3,732	45 Added 0.7%	6,459 $536 Million
Q2 2020 Jun 17, 2024	SELL	$70.42 - $80.13 $141,262 - $160,740	-2,006 Reduced 23.82%	6,414 $496 Million
Q1 2020 Jun 17, 2024	SELL	$63.36 - $87.82 $155,548 - $215,598	-2,455 Reduced 29.16%	5,965 $459 Million
Q4 2019 Jun 17, 2024	SELL	$77.58 - $87.54 $260,436 - $293,871	-3,357 Reduced 39.87%	5,063 $461 Million
Q3 2019 Jun 17, 2024	SELL	$76.08 - $82.93 $440,351 - $479,998	-5,788 Reduced 68.74%	2,632 $222 Million
Q2 2019 Jun 17, 2024	SELL	$69.84 - $81.59 $404,513 - $472,569	-5,792 Reduced 68.79%	2,628 $220 Million
Q1 2019 Jun 17, 2024	SELL	$69.58 - $79.36 $408,225 - $465,605	-5,867 Reduced 69.68%	2,553 $212 Million

Others Institutions Holding MRK

# of Institutions

3,824

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $257B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Traphagen Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Traphagen Investment Advisors LLC with notifications on news.

Account

Traphagen Investment Advisors LLC Merck & Co., Inc. Transaction History